FDA Approves Expanded Monotherapy Label for Merck’s KEYTRUDA® (pembrolizumab)
KEYTRUDA Now Approved for First-Line Treatment of Patients with Stage III NSCLC Who Are Not Candidates for Surgical Resection or…
Pharmaceuticals, Biotechnology and Life Sciences
KEYTRUDA Now Approved for First-Line Treatment of Patients with Stage III NSCLC Who Are Not Candidates for Surgical Resection or…
Appointments effective as of April 29, 2019 Dr. Richard M. Glickman to retire from executive and board roles and remain…
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) todayannounced the launch of a generic version of AndroGel ®i(testosterone gel) 1.62% CIII in the U.S.
Ophtotech entered into an exclusive global licenseagreement for rights to developand commercialize novel adeno-associated virus (AAV) gene therapyproduct candidates for the treatment of Best vitelliform maculardystrophy.
CAMBRIDGE, Mass.–(BUSINESS WIRE)–X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the…
As the U.S. continues to grapple with solutions to the national opioidaddiction epidemic, Brentwood-based Corizon Health is preparing to offera successful treatment pilot to additional communities the companyserves across the U.S.
DUBLIN–(BUSINESS WIRE)–The “North America Metagenomics Market to 2027- Regional Analysis and Forecasts by Product, Application and Country” report has been…
ANN ARBOR, Mich. & LANSING, Mich.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/bioscience?src=hash" target="_blank"gt;#biosciencelt;/agt;–Yesterday, representatives from more than twenty-five Michigan bioscience organizations were joined by…
DUBLIN–(BUSINESS WIRE)–The “Europe Metagenomics Market to 2027 – Regional Analysis and Forecasts by Product, Application and Country” report has been…
Order backlog of €23.7m 2018 full year revenues of €6.3m Cash and cash equivalents of €12.7m, with significantly reduced burn…